Prognostic factors for survival after autologous
transplantation: a single centre experience in 133 multiple
myeloma patients.

J 2005

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.

KREJČÍ, Marta, Tomáš BÜCHLER, Roman HÁJEK, A. SVOBODNÍK, Andrea KŘIVANOVÁ et. al.

Basic information

Original name

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.

Name in Czech

Prognostické faktory přežití po autologní transplantaci: zkušenosti jednoho centra se 133 pacienty s mnohočetným myelomem

Authors

KREJČÍ, Marta (203 Czech Republic, guarantor), Tomáš BÜCHLER (703 Slovakia), Roman HÁJEK (203 Czech Republic), A. SVOBODNÍK (203 Czech Republic), Andrea KŘIVANOVÁ (203 Czech Republic), Luděk POUR (203 Czech Republic), Zdeněk ADAM (203 Czech Republic), Jiří MAYER (203 Czech Republic) and Jiří VORLÍČEK (203 Czech Republic)

Edition

Bone Marrow Transplantation, London, Nature Publishing Group, 2005, 0268-3369

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.643

RIV identification code

RIV/00216224:14110/05:00035910

Organization unit

Faculty of Medicine

UT WoS

000226245100008

Keywords (in Czech)

mnohočetný myelom

Keywords in English

multiple myeloma; autologous stem cell transplantation

Abstract

ORIG CZ

V originále

Autologous stem cell transplantation (ASCT) has an established role in the treatment of symptomatic multiple myeloma (MM). Our aim was to analyse the impact of selected prognostic parameters on the survival of patients with MM after ASCT. The new International Staging System (ISS) was also evaluated. A total of 133 MM patients were transplanted in our centre between 1995 and 2002. Following ASCT, 35% of patients were in complete remission (CR) and 60% were in partial remission (PR). The median progression-free (PFS) and overall (OS) survival from transplantation were 29.5 and 68.8 months, respectively. Transplant-related mortality (TRM) was 3%. On multivariate analysis, factors associated with significantly shorter OS were lack of CR after transplant (P = 0.002, hazard ratio (HR): 3.1), stage 3 according to ISS (P = 0.001, HR: 3.0) and age at transplant over 60 years (P = 0.035, HR: 2.0). The status of disease before ASCT did not significantly affect PFS and OS after transplantation. We conclude that ASCT is a safe and effective procedure in MM patients, associated with low TRM. The survival after ASCT was dependent on response after ASCT, stage according to ISS and age.

In Czech

Cílem této práce bylo srovnat význam vybraných prognostických parametrů na přežívání pacientů s MM po transplantaci.

Citovat

KREJČÍ, Marta, Tomáš BÜCHLER, Roman HÁJEK, A. SVOBODNÍK, Andrea KŘIVANOVÁ, Luděk POUR, Zdeněk ADAM, Jiří MAYER and Jiří VORLÍČEK. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow Transplantation. London: Nature Publishing Group, 2005, vol. 35, No 2, p. 159-164. ISSN 0268-3369.

@article{837975,
   author = {Krejčí, Marta and Büchler, Tomáš and Hájek, Roman and Svobodník, A. and Křivanová, Andrea and Pour, Luděk and Adam, Zdeněk and Mayer, Jiří and Vorlíček, Jiří},
   article_location = {London},
   article_number = {2},
   keywords = {multiple myeloma; autologous stem cell transplantation},
   language = {eng},
   issn = {0268-3369},
   journal = {Bone Marrow Transplantation},
   title = {Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.},
   volume = {35},
   year = {2005}
}

TY  - JOUR
ID  - 837975
AU  - Krejčí, Marta - Büchler, Tomáš - Hájek, Roman - Svobodník, A. - Křivanová, Andrea - Pour, Luděk - Adam, Zdeněk - Mayer, Jiří - Vorlíček, Jiří
PY  - 2005
TI  - Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.
JF  - Bone Marrow Transplantation
VL  - 35
IS  - 2
SP  - 159-164
EP  - 159-164
PB  - Nature Publishing Group
SN  - 02683369
KW  - multiple myeloma
KW  - autologous stem cell transplantation
N2  - Autologous stem cell transplantation (ASCT) has an established role in the treatment of symptomatic multiple myeloma (MM). Our aim was to analyse the impact of selected prognostic parameters on the survival of patients with MM after ASCT. The new International Staging System (ISS) was also evaluated. A total of 133 MM patients were transplanted in our centre between 1995 and 2002. Following ASCT, 35% of patients were in complete remission (CR) and 60% were in partial remission (PR). The median progression-free (PFS) and overall (OS) survival from transplantation were 29.5 and 68.8 months, respectively. Transplant-related mortality (TRM) was 3%. On multivariate analysis, factors associated with significantly shorter OS were lack of CR after transplant (P = 0.002, hazard ratio (HR): 3.1), stage 3 according to ISS (P = 0.001, HR: 3.0) and age at transplant over 60 years (P = 0.035, HR: 2.0). The status of disease before ASCT did not significantly affect PFS and OS after transplantation. We conclude that ASCT is a safe and effective procedure in MM patients, associated with low TRM. The survival after ASCT was dependent on response after ASCT, stage according to ISS and age.
ER  -

KREJČÍ, Marta, Tomáš BÜCHLER, Roman HÁJEK, A. SVOBODNÍK, Andrea KŘIVANOVÁ, Luděk POUR, Zdeněk ADAM, Jiří MAYER and Jiří VORLÍČEK. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. \textit{Bone Marrow Transplantation}. London: Nature Publishing Group, 2005, vol.~35, No~2, p.~159-164. ISSN~0268-3369.

Detailed Information on Publication Record